针注射和电刺激治疗术后恶心和吐:一项随机临床试验
Ling Zhou1, Li-Hua Peng1, Tong Mu1
1Department of Anaesthesiology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China.
概括
德克萨米他注射到Neiguan针点有效地减少了妇科手术患者的术后恶心和吐 (PONV). 将针注射 (AI) 与截面电针刺激 (TEAS) 结合起来,降低了PONV发病率和救援抗药需求.
科学领域:
- 麻醉学和疼痛管理
- 整合和补充医学是整合和补充医学.
- 手术护理 医疗护理
背景情况:
- 手术后恶心和吐 (PONV) 是妇科腹腔镜手术后的一个常见并发症.
- 有效的管理策略对于改善患者的康复和满意度至关重要.
- 传统的抗emetic疗法可能有局限性或副作用.
研究的目的:
- 评估德克萨米他针点注射 (AI) 与皮肤过渡电针点刺激 (TEAS) 结合用于PONV预防的疗效和安全性.
- 将组合疗法与单独的AI,单独的TEAS和对照组进行比较.
- 评估对PONV发病率,严重程度,抗使用和患者满意度的影响.
主要方法:
- 一项随机对照试验,涉及160名接受妇科腹腔镜手术的患者.
- 参与者被分配到四个组:AI + TEAS,仅AI,仅TEAS或对照组.
- 主要结局:手术后0-24小时内PONV发生率. 二次结局包括其他间隔的PONV,症状得分,抗使用和患者满意度.
主要成果:
- 与对照组 (37.5%) 相比,AI + TEAS组和AI组组合显示PONV发病率明显较低 (17.5%).
- 在TEAS组 (22.5%) 和对照组之间没有发现PONV发病率的显著差异.
- 与对照组相比,AI + TEAS组所需的救援抗药剂剂量显著减少.
结论:
- 德克萨米他注射到Neiguan针点是有效的降低PONV风险.
- 结合针注射和TEAS进一步减少PONV和救援抗药的需要.
- 人工智能和TEAS干预都有助于提高患者满意度.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
267
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
332
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
332
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
467
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
467
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
373
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
373


